Thus, selective inhibition of the glycosylation enzymes that are responsible for core fucosylation, e.g., α1,6-fucosyltransferase (FUT8), will likely attenuate increased core fucosylation that was found on these glycoproteins in HCC tumor and serves as a potential therapeutic strategy for HCC. The gene discussed is FUT8; the disease is hepatocellular carcinoma.